Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients (Q33679736)

28 July 2017

title

Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients (English)

1 reference

28 July 2017

Hyon-Suk Kim

0 references

Seri Jeong

1 reference

28 July 2017

Seho Park

1 reference

28 July 2017

Byeong-Woo Park

1 reference

28 July 2017

Younhee Park

1 reference

28 July 2017

Oh-Joong Kwon

1 reference

28 July 2017

language of work or name

English

0 references

publication date

28 May 2014

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

e98284

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

start time

28 May 2014

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Human leukocyte antigen-G in cancer: Are they clinically relevant?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Human Leukocyte Antigen G Expression in Breast Cancer: Role in Immunosuppression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G: from biology to clinical benefits

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

The global breast cancer burden: variations in epidemiology and survival.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G in human reproduction: aspects of genetics, function and pregnancy complications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Effect of screening and adjuvant therapy on mortality from breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Detection of HLA-G5 secreting cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G polymorphisms and allele frequencies in Caucasians

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

The polymorphism of human leucocyte antigen-G gene in a healthy population of Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

Relationship between HLA-G gene polymorphism and the susceptibility of esophageal cancer in Kazakh and Han nationality in Xinjiang

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0098284

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037222

Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer

30 October 2018

1 reference

12 December 2020

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients

1 reference

12 December 2020

Up‐regulation of HLA‐G expression in cervical premalignant and malignant lesions

1 reference

12 December 2020

Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer

1 reference

12 December 2020

HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma

1 reference

12 December 2020

Association ofHLA-G3′ UTR 14-bp Insertion/Deletion Polymorphism with Hepatocellular Carcinoma Susceptibility in a Chinese Population

1 reference

12 December 2020

Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy

1 reference

12 December 2020

Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis

1 reference

12 December 2020

Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma

1 reference

12 December 2020

14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population

1 reference

12 December 2020

HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group

1 reference

12 December 2020

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0098284

Identifiers

DOI

1 reference

release_q5igonid4ngv5dhpiifhk7qpqy

28 July 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q5igonid4ngv5dhpiifhk7qpqy

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4037222

1 reference

28 July 2017

1 reference